標(biāo)題: Titlebook: Critical Issues in Head and Neck Oncology; Key concepts from th Jan B. Vermorken,Volker Budach,Brian O‘Sullivan Conference proceedings 2017 [打印本頁] 作者: Tyler 時間: 2025-3-21 17:09
書目名稱Critical Issues in Head and Neck Oncology影響因子(影響力)
書目名稱Critical Issues in Head and Neck Oncology影響因子(影響力)學(xué)科排名
書目名稱Critical Issues in Head and Neck Oncology網(wǎng)絡(luò)公開度
書目名稱Critical Issues in Head and Neck Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Critical Issues in Head and Neck Oncology被引頻次
書目名稱Critical Issues in Head and Neck Oncology被引頻次學(xué)科排名
書目名稱Critical Issues in Head and Neck Oncology年度引用
書目名稱Critical Issues in Head and Neck Oncology年度引用學(xué)科排名
書目名稱Critical Issues in Head and Neck Oncology讀者反饋
書目名稱Critical Issues in Head and Neck Oncology讀者反饋學(xué)科排名
作者: 百科全書 時間: 2025-3-21 23:17
ck cancer and discussing side effects, survivorship issues and treatment in the elderly, this book?provides and up-to-date coverage of all the critical topics in the field. Highlighting t978-3-319-82691-2978-3-319-42909-0作者: Entropion 時間: 2025-3-22 00:54 作者: Reclaim 時間: 2025-3-22 05:04
Multidisciplinary Decision Making and Head and Neck Tumor Boardsrs, and (4) the decision of the patient himself/herself. The attitude of the patient in this decision making, being negative or positive, is in that respect extremely important. It has become increasingly apparent that patients need emotional support, not only to navigate through their cancer journe作者: Tractable 時間: 2025-3-22 11:27 作者: Anecdote 時間: 2025-3-22 13:52
Treatment of Viral-Associated HNC (OPC and NPC)duced compliance to subsequent CCRT remains the biggest drawback to this approach..Current research for HPV+ OPC is refining risk groups and exploring deintensification in low-risk groups and maintaining or augmenting intensification in the high-risk group. Ang et al. constructed two mortality risk 作者: Anecdote 時間: 2025-3-22 19:31 作者: 潛移默化 時間: 2025-3-22 21:56
Recurrent/Metastatic Head and Neck Cancer: When and How to Irradiatef reirradiation for recurrent laryngeal cancer). Optimizing the therapeutic ratio of reirradiation requires consideration of several strategies that may facilitate the goal of disease control with reduction of morbidity. The latter may include hyper-fractionation (employing smaller than usual fracti作者: AXIS 時間: 2025-3-23 04:04
Healthcare System Stakeholders,on, the current role of .F-fluorodeoxyglucose (.F-FDG) PET is addressed, and non-FDG PET tracers including tracers for hypoxia and epidermal growth factor receptor (EGFR) imaging are discussed. We describe development of EGFR imaging with fluorescence and address preclinical imaging results in HNSCC作者: urethritis 時間: 2025-3-23 08:49 作者: flamboyant 時間: 2025-3-23 11:07 作者: Melanocytes 時間: 2025-3-23 16:19
duced compliance to subsequent CCRT remains the biggest drawback to this approach..Current research for HPV+ OPC is refining risk groups and exploring deintensification in low-risk groups and maintaining or augmenting intensification in the high-risk group. Ang et al. constructed two mortality risk 作者: 連鎖 時間: 2025-3-23 21:14 作者: left-ventricle 時間: 2025-3-24 01:21 作者: intimate 時間: 2025-3-24 05:23 作者: aquatic 時間: 2025-3-24 10:35 作者: URN 時間: 2025-3-24 12:30 作者: 采納 時間: 2025-3-24 16:11 作者: 神圣將軍 時間: 2025-3-24 20:13
Molecular Imaging in Head and Neck Squamous Cell Carcinoma Patientse staging and tumor delineation are essential for determination of a personalized treatment strategy. Molecular imaging with radionuclides or fluorescent probes allows visualization of tumor biology in vivo. Positron emission tomography (PET) imaging gives whole body information with low resolution 作者: ingrate 時間: 2025-3-25 01:41
Multidisciplinary Decision Making and Head and Neck Tumor Boardshis is evident by the fact that treatments are becoming more complex, new forms of treatment in different professional areas are becoming available at a more rapid pace, and there is a trend towards personalized medicine. Although it seems self-evident that the variety of specialist team members wit作者: MORPH 時間: 2025-3-25 04:33
Pros and Cons of Endoscopic Surgeryvative techniques introduced during the last decades in head and neck surgical oncology. The aim of these technologies is to provide patients with treatments associated with the same outcome in terms of local control compared to traditional surgical techniques or radiation/chemoradiation (RT/CRT), b作者: 車床 時間: 2025-3-25 09:13
Comprehensive Overview: Definitive Radiotherapy and Concurrent Chemoradiation in Locally Advanced Heion versus standard fractionation led to a small but significant absolute OS benefit of 3.4 % at 5 years in patients with LAD-HNSCC corresponding to a HR reduction for death of 8 %. Hyperfractionation as a specific subtype of altered fractionation led to a highly significant absolute OS and LRC bene作者: 嚴(yán)重傷害 時間: 2025-3-25 13:42
Treatment of Viral-Associated HNC (OPC and NPC)ement is applicable to both..NPC is primarily treated with radiotherapy (RT), because of anatomical location that poses a technical challenge for surgery. IMRT is the technique of choice, particularly for locally advanced disease. Patients with stage I and II NPC are managed with RT-alone, but concu作者: 引起痛苦 時間: 2025-3-25 16:37
Patient and Treatment Factors in Concurrent ChemoradiotherapyRT) alone. High-dose cisplatin (100 mg/m. on days 1, 22, and 43 during RT) was identified as the most effective regimen. Definitive CCRT with high-dose cisplatin is therefore regarded as the preferred choice for the treatment of locoregionally advanced head and neck squamous cell cancer. However, th作者: TIA742 時間: 2025-3-25 22:03
Recurrent/Metastatic Head and Neck Cancer: When and How to Irradiateregional vs. distant), availability of salvage options in each institution, and patient performance status. The general philosophy underpinning its management is to generally use a different treatment modality compared to what was employed initially. For cases treated with surgery without radiothera作者: Mechanics 時間: 2025-3-26 00:55
E. Striegnitz,C. von Reibnitz,A. Skowronskyrent backgrounds were involved in this, but also representatives of European Cancer Leagues, the European Cancer Coalition (ECPC), patient groups, the European School of Oncology (ESO), the Roy Castle Lung Cancer Foundation, coworkers of Merck and a journalist. The background and evolution of this initiative is subject of this presentation.作者: exercise 時間: 2025-3-26 07:26 作者: Carcinoma 時間: 2025-3-26 09:02 作者: Ige326 時間: 2025-3-26 16:21
https://doi.org/10.1007/978-3-662-55909-3pretation. Through attendance at tumour boards or multi-disciplinary team meetings, pathologists can also provide interpretation of pathology testing in the clinical context, alongside imaging and other investigations.作者: 語源學(xué) 時間: 2025-3-26 19:50
Der Hintergrund der Compliance,ut with less morbidity and decreased hospitalization time. The value of TLM, TORS, and TES in the management of early-stage lesions is widely recognized, while the debate is still ongoing on their role in the treatment of selected intermediate/advanced tumors.作者: zonules 時間: 2025-3-27 00:49
hallenges in diagnosis and management.This book offers a selection of the critical current issues and challenges in head and neck cancer.? It covers most key?concepts of the subject, from diagnostic challenges to multidisciplinary decision-making aspects in head and neck oncology. Starting with the 作者: 厭惡 時間: 2025-3-27 04:21
The “Make Sense Campaign”: An Initiative of the European Head and Neck Societyrent backgrounds were involved in this, but also representatives of European Cancer Leagues, the European Cancer Coalition (ECPC), patient groups, the European School of Oncology (ESO), the Roy Castle Lung Cancer Foundation, coworkers of Merck and a journalist. The background and evolution of this initiative is subject of this presentation.作者: lesion 時間: 2025-3-27 05:34
New Epidemiologic Aspects in Head and Neck Cancers]. H&N, as all the rare cancers, suffer of difficulties in making correct diagnosis, definition of appropriate treatment, problems in research for the low number of cases and in the organisation of the patients management.作者: Bone-Scan 時間: 2025-3-27 13:24
The Biology of Head and Neck Cancersingly clear that non-mutational (epigenetic) changes that affect patterns of gene transcription play a key role in the process. In addition to effects that occur in cancer cells, there is a growing understanding of the influence of changes in the so-called tumour microenvironment (TME) on the biological behaviour of cancers.作者: GLOOM 時間: 2025-3-27 14:02 作者: 說不出 時間: 2025-3-27 18:59 作者: 惡意 時間: 2025-3-28 01:21 作者: escalate 時間: 2025-3-28 05:09
Jan B. Vermorken,Volker Budach,Brian O‘SullivanProvides an overview of the most up-to-date information on head and neck cancer.Offers a multidisciplinary approach to the topic.Discusses challenges in diagnosis and management作者: Altitude 時間: 2025-3-28 06:50
http://image.papertrans.cn/d/image/240012.jpg作者: 松緊帶 時間: 2025-3-28 12:45
E. Striegnitz,C. von Reibnitz,A. Skowronsky and the general public. This Think Tank came together for the first time in January 2012 in London at the invitation of the European Head and Neck Cancer Society (EHNS) in collaboration with and support of Merck, previously Merck Serono (Darmstadt, Germany). Not only oncology professionals of diffe作者: tenosynovitis 時間: 2025-3-28 17:51 作者: Pseudoephedrine 時間: 2025-3-28 20:11
,Weihrauch (Olibanum) – was ist das?,t, the effects of normal genes that control normal cellular functions, such as growth, survival and invasion/motility, are enhanced and those of genes that act to suppress these effects are repressed. The main mechanism of genetic alteration is through the accumulation of mutations, but it is increa作者: 尖 時間: 2025-3-28 23:09
https://doi.org/10.1007/978-3-662-55909-3 and cytopathology written reports to the creation of more clinically apposite integrated reports for precision medicine. Increasingly, pathologists are playing an expanded role in the oncology clinical team, having greater responsibility for integration of molecular testing with morphological inter作者: 擋泥板 時間: 2025-3-29 05:44 作者: nitric-oxide 時間: 2025-3-29 10:39
Healthcare System Stakeholders,his is evident by the fact that treatments are becoming more complex, new forms of treatment in different professional areas are becoming available at a more rapid pace, and there is a trend towards personalized medicine. Although it seems self-evident that the variety of specialist team members wit作者: 誘拐 時間: 2025-3-29 14:50 作者: 發(fā)微光 時間: 2025-3-29 17:16
ion versus standard fractionation led to a small but significant absolute OS benefit of 3.4 % at 5 years in patients with LAD-HNSCC corresponding to a HR reduction for death of 8 %. Hyperfractionation as a specific subtype of altered fractionation led to a highly significant absolute OS and LRC bene作者: orthodox 時間: 2025-3-29 21:12
